Breuer Christian, Lemke Carina, Schmitz Janina, Bartz Ulrike, Gütschow Michael
Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany; Department of Natural Sciences, University of Applied Sciences Bonn-Rhein-Sieg, von-Liebig-Strasse 20, D-53359 Rheinbach, Germany.
Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany.
Bioorg Med Chem Lett. 2018 Jun 15;28(11):2008-2012. doi: 10.1016/j.bmcl.2018.05.005. Epub 2018 May 4.
A series of inhibitors targeting human cathepsins have been designed and synthesized following a combinatorial approach. The compounds bear an α,β-unsaturated phenyl vinyl sulfone or ethyl acrylate warhead and a peptidomimetic portion aligned to the non-primed binding region. Biochemical evaluation toward four human cathepsins was carried out and the kinetic characterization confirmed an irreversible mode of inhibition. Compound 6c combining the most advantageous building blocks for cathepsin S inhibition was identified as a potent cathepsin S inactivator exhibiting a second-order rate constant of 30600 M s.
通过组合方法设计并合成了一系列靶向人组织蛋白酶的抑制剂。这些化合物带有α,β-不饱和苯基乙烯基砜或丙烯酸乙酯弹头以及与非引发结合区域对齐的拟肽部分。对四种人组织蛋白酶进行了生化评估,动力学表征证实了不可逆的抑制模式。结合了抑制组织蛋白酶S最有利结构单元的化合物6c被鉴定为一种有效的组织蛋白酶S失活剂,其二阶速率常数为30600 M⁻¹s⁻¹。